435 related articles for article (PubMed ID: 7689191)
21. Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.
Schaller B
Pituitary; 2002; 5(4):247-53. PubMed ID: 14558673
[TBL] [Abstract][Full Text] [Related]
22. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha-subunit levels in patients with pituitary adenomas.
Samejima N; Yamada S; Takada K; Sano T; Ozawa Y; Shimizu T; Usui M; Shishiba Y
Clin Endocrinol (Oxf); 2001 Apr; 54(4):479-84. PubMed ID: 11318783
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the serum hormone levels and histological findings in pituitary adenomas.
Irsy G; Góth M; Bálint K; Slowik F; Szabolcs I; Pásztor E; Szilágyi G
Exp Clin Endocrinol; 1986 Dec; 88(2):224-36. PubMed ID: 3104069
[TBL] [Abstract][Full Text] [Related]
26. Histopathological analyses of silent pituitary somatotroph adenomas using immunohistochemistry, in situ hybridization and confocal laser scanning microscopic observation.
Matsuno A; Itoh J; Itoh Y; Osamura RY; Katayama H; Nagashima T
Pathol Res Pract; 2001; 197(1):13-20. PubMed ID: 11209812
[TBL] [Abstract][Full Text] [Related]
27. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
[TBL] [Abstract][Full Text] [Related]
28. Morphological effects of octreotide on growth hormone-producing pituitary adenomas.
Ezzat S; Horvath E; Harris AG; Kovacs K
J Clin Endocrinol Metab; 1994 Jul; 79(1):113-8. PubMed ID: 8027215
[TBL] [Abstract][Full Text] [Related]
29. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Acta Endocrinol (Copenh); 1989 Aug; 121(2):270-8. PubMed ID: 2549755
[TBL] [Abstract][Full Text] [Related]
31. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
Nishioka H; Haraoka J; Akada K
Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
33. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
34. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural classification of pituitary adenomas.
Horvath E; Kovacs K
Can J Neurol Sci; 1976 Feb; 3(1):9-21. PubMed ID: 175909
[TBL] [Abstract][Full Text] [Related]
36. Human pituitary somatotroph adenoma and prolactinoma: an ultrastructural and immunoelectron microscopical study.
Zhou XJ; Zhang TH; Yu YQ; Wang FA
J Tongji Med Univ; 1990; 10(2):83-7. PubMed ID: 2213957
[TBL] [Abstract][Full Text] [Related]
37. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
Kawakita S; Asa SL; Kovacs K
J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone and prolactin in tissue culture of pituitary adenoma.
Demura R; Kubo O; Odagiri E; Nomura K; Yamaguchi H
Endocrinol Jpn; 1977 Jun; 24(3):259-64. PubMed ID: 913336
[TBL] [Abstract][Full Text] [Related]
39. Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study.
Holm R; Nesland JM; Attramadal A; Reinli S; Johannessen JV
J Submicrosc Cytol Pathol; 1989 Apr; 21(2):339-50. PubMed ID: 2752363
[TBL] [Abstract][Full Text] [Related]
40. Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: a retrospective cohort study.
Dehghani M; Davoodi Z; Bidari F; Moghaddam AM; Khalili D; Bahrami-Motlagh H; Jamali E; Alamdari S; Hosseinpanah F; Hedayati M; Valizadeh M
BMC Endocr Disord; 2021 Sep; 21(1):186. PubMed ID: 34530798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
